Marapharm Ventures Inc. is a publicly traded company on the Canadian Stock Exchange investing in the medical and recreational cannabis sector, with corporate operations based in British Columbia, Canada. Since 2016, they have rapidly expanded their footprint to include production locations in the key states of Washington, Nevada, and California. In other words, this company is a rising prospect, and definitely one to watch for important cannabis news.
Marapharm just announced that 4,633,348 Canadian Dollars has been received from the exercise of warrants. This equals roughly $3,824,630 at current foreign exchange rates. The warrants were issued in a unit offering containing one common share and one share purchase warrant. The right to exercise these warrants expired on Sept. 6, 2017 at 5 PM PST. While there are no more unit offerings with warrants to be exercised at this time, there is a “warrant only” offering announced Aug. 8, 2017 still outstanding.
“We are very pleased that our shareholders continue to show confidence in Marapharm as evidenced by the exercise of their warrants,” said Linda Sampson, Marapharm CEO.